The information contained on this page is provided by the respective companies noted. It does not necessarily reflect the Society’s viewpoint and may redirect the user to a third-party site. ASE has posted this content on ContrastZone as a convenient way to access multiple pieces of information in one place, in alignment with our Society’s goal to provide resources and education to enhance the access to and quality in cardiovascular ultrasound.
Bracco Diagnostics
December 2019: LUMASON is now approved for pediatric patients with suboptimal echocardiograms.
September 2019: Test your skills at GreatSonographer.com, an interactive and educational program that illustrates the value of ultrasound contrast.
March 2016: LUMASON is now FDA approved for use in ultrasonography of the liver
Please read the press release and prescribing information for more information.
Lumason Formulary Kit: includes Lumason Product Monograph, Safety Data Sheet, FDA Approval Letter, and Prescribing Information
Lumason Brochure: overview of products (Updated Brochure coming soon)
2019 LUMASON® Reimbursement Guide
November 2015: Lumason® approved for reimbursement by CMS
To learn more about how to code Bracco’s new ultrasound contrast agent, visit here and read the press release here.
GE Healthcare
FDA removes hypersensitivity to blood and blood products contraindication for Optison
GE ultrasound contrast agent Optison gets FDA OK for label change
Optison Dosing, Handling, & Administration Training Video
Quick Reference Guide for Using Optison
Additional Optison resources including case studies, educational programs and a reimbursement guide
Optison Prescribing Information
Lantheus Medical Imaging
DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension
Lantheus Medical Imaging, Inc.
DEFINITY® Prescribing Information
